Peptides Bioscience
Analytical methods & quality controls

Quality & Testing

Every lot we list is analyzed and documented before it is released for laboratory use. This page describes the instruments, methods, and documentation chain applied to each batch — not what any compound does in a biological system.

Research Use Only. All materials are sold strictly for in-vitro laboratory research. They are not drugs, supplements, or medical devices, and are not intended for human or veterinary use. Analytical data describes the material as shipped; it does not imply any biological effect.

Analytical methods

Each lot is characterized using orthogonal techniques so identity and purity are confirmed by independent measurements.

RP-HPLC — Purity

Reverse-phase high-performance liquid chromatography separates the target peptide from synthesis byproducts, truncated sequences, and counter-ions. Purity is reported as the integrated peak area at a defined wavelength (typically 214 nm) against the total chromatogram.

ESI-MS — Identity

Electrospray ionization mass spectrometry confirms the molecular mass of the peptide against its theoretical monoisotopic and average masses. A mass match within the method's tolerance window is required for identity release.

Visual & physical inspection

Lyophilized cake appearance, color, and reconstitution behavior are checked against reference standards. Vials with cake collapse, discoloration, or particulate matter are quarantined and not released.

Lyophilization & fill

Peptides are filled into Type I borosilicate vials and freeze-dried under controlled shelf temperature and vacuum to produce a stable amorphous cake suitable for cold-chain storage.

Lot traceability

Every vial carries a lot number that ties back to the raw material source, fill date, analytical instruments used, and the issued Certificate of Analysis. Records are retained for the documented shelf life of the lot.

Cold-chain handling

Finished lots are stored and shipped under temperature-controlled conditions appropriate for lyophilized peptides. Shipping is timed to minimize transit, and customers are advised on receiving and storage handling.

Release process

A lot is not made available for order until each of the following steps is complete and documented.

  1. 1

    Raw material intake

    Incoming peptide is logged with supplier reference, lot, and date of receipt. Documentation is reviewed before any further processing.

  2. 2

    Analytical testing

    RP-HPLC purity and ESI-MS identity are performed against pre-defined acceptance criteria. Out-of-spec material is quarantined.

  3. 3

    Independent COA issuance

    A Certificate of Analysis is issued by an independent analytical laboratory and is made available in the public COA Library.

  4. 4

    Fill, finish & label

    Material is filled, lyophilized where applicable, and labeled with lot number, fill date, and RUO statement.

  5. 5

    Cold storage

    Finished vials are placed into temperature-controlled storage pending release for sale.

  6. 6

    Release for order

    A second reviewer confirms documentation is complete before the lot is published to the catalog.

What this page describes

  • Instruments and methods used to characterize each lot
  • The release workflow from raw material to catalog availability
  • How lot numbers, COAs, and storage records are maintained

What this page does not describe

  • Any biological, physiological, or clinical effect of any compound
  • Dosing, cycling, protocols, or administration of any kind
  • Medical, veterinary, or therapeutic guidance

Review the analytical records

Every released lot is documented in the public COA library.

View COA LibraryMethods reference